| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |